ACE protocol 1
(UDIODXADSSQKTM-GUHNCMMLSA-N)
Structure
- SMILES
- OCC(=O)[C@@]1(O)C[C@H](O[C@H]2C[C@H](N)[C@@H]([C@@H](O2)C)O)c2c(C1)c(O)c1c(c2O)C(=O)c2c(C1=O)cccc2OC.COc1cc(cc(c1O)OC)[C@H]1[C@H]2C(=O)OC[C@@H]2C(c2c1cc1OCOc1c2)O[C@@H]1O[C@@H]2CO[C@H](O[C@H]2[C@@H]([C@H]1O)O)C.ClCCN(P1(=O)NCCCO1)CCCl
- Molecular Formula:
- C63H76Cl2N3O26P
- Molecular Weight:
- 1393.160
- Log P:
- 4.2530
- Hydrogen Bond Acceptor:
- 29
- Hydrogen Bond Donor:
- 10
- TPSA:
- 418.28
- CAS Number(s):
- N/A
Synonym(s)
1.
ACE protocol 1
2.
CAE protocol
3.
CAVP protocol 2
4.
CAVP-16 protocol
5.
CAVP16
6.
CDE protocol
7.
DEC regimen
External Link(s)
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Adenocarcinoma | 7512436 | CTD | |
| 2 | Lymphoma, Non-Hodgkin | 16110137 | CTD | |
| 3 | Lymphoma | 8562950 | CTD |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120269
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.